Search results “Seroquel for lewy body disease”
Parkinsons Disease Dementia
Table of Contents: 00:05 - Objectives 00:17 - Objectives, Continued 00:27 - Facts about Parkinson’s Disease 00:37 - Risk Factors for PD 01:27 - Early Signs of Parkinsons 01:47 - Hallmarks of PD 01:59 - PPathophysiology of PD 02:33 - Death of Dopamine Producing Cells 02:42 - Parkinson’s Disease Dementia 03:04 - PD Dementia : Symptoms 03:49 - Lewy Bodies 04:56 - Visual Hallucinations in PDD 05:35 - 05:45 - PDD vs AD 06:05 - Role of Neurotransmitters 07:05 - Role of Acetylcholine (Ach) 07:45 - Overview: Treating PDD 08:06 - Treatment Dilemmas with PDD 08:33 - Medications to Avoid in PDD 08:50 - Treatment of Dementia Symptoms: Cholinesterase Inhibitors 09:18 - Aricept (donepezil), cont. 09:34 - Major Drug Interactions: Aricept 09:45 - Excelon (Rivastigmine) 10:07 - Rivastigmine: Drug Interactions 10:19 - Rivastigmine: Drug Interactions 10:28 - Treating Psychosis 10:47 - Management of Psychosis 11:11 - Seroquel (Quetiapine) 11:32 - Seroquel (Quetiapine) 11:46 - Clozaril (Clozapine): 12:05 - Clozaril (Clozapine): Side Effects: 12:17 - Clozapine: Drug Interactions 12:33 - Nuplazid (Pimavanserin) 13:08 - Nuplazid (Pimavanserin) 13:32 - Nuplazid (Pimavanserin) 13:47 - Acute Delirium vs Psychosis 14:21 - Caution: Memantine 14:32 - Melatonin 15:03 - Melatonin Pathway 15:14 - Conclusion 15:23 - For More Information 15:29 - References 15:29 - References, Cont. 15:30 - References, Cont. 15:30 - References, Cont. 15:31 - References, Cont.
Views: 517 wcrdm8
Neuroleptic Induced Parkinsonism
Neuroleptic Induced Parkinsonism Instructional Tutorial Video CanadaQBank.com QBanks for the MCCEE, MCCQE & USMLE
Views: 15672 CanadaQBank
Understanding Behavioral Challenges in Lewy Body Dementia
On Thursday, June 18 Lewy Body Dementia Association in collaboration with NASDA offered a free 1-hour webinar on “Understanding Behavioral Challenges in Lewy Body Dementia” featuring guest speaker, Glenn E. Smith, PhD, LP, professor of psychology at Mayo Clinic in Rochester, MN. Dr. Smith explained the difference between Lewy body dementia (LBD), Alzheimer’s disease and Parkinson’s disease and how LBD can affect a person’s behavior. Attendees will learn why a one-size-fits-all approach to behavioral changes in dementia does not work, as well as strategies that may be helpful with individuals with LBD.
Views: 12562 LBDAtv
Parkinsons Disease Dementia
Table of Contents: 00:36 - Parkinson’s Disease Dementia 00:50 - Objectives 01:03 - Objectives, Continued 01:11 - Facts about Parkinson’s Disease 01:22 - Risk Factors for PD 02:38 - Hallmarks of PD 03:03 - Early Signs of Parkinsons 03:29 - PPathophysiology of PD 04:04 - Death of Dopamine Producing Cells 04:21 - Neurons Produce Less Dopamine 04:32 - Not Just a Movement Disorder 04:43 - Parkinson’s Disease Dementia: Prevalence 05:01 - Parkinson’s Disease Dementia 05:27 - Lewy Bodies 06:21 - Symptoms Parkinson’s Disease Dementia 06:44 - PDD: More Symptoms 07:26 - Visual Hallucatinations in PDD 08:15 - Differentiating Types of Dementia 08:34 - 08:54 - PDD vs AD 09:17 - Role of Neurotransmitters 10:01 - Role of Acetylcholine (Ach) 11:12 - Treating PDD 11:40 - Treatment Dilemmas with PDD 12:12 - Medications to Avoid in PDD 12:29 - Treatment of Dementia Symptoms: Cholinesterase Inhibitors 12:52 - Aricept (donepezil), cont. 13:20 - Major Drug Interactions: Aricept 13:32 - Excelon (Rivastigmine) 13:56 - Rivastigmine: Drug Interactions 14:15 - Rivastigmine: Drug Interactions 14:23 - Treating Psychosis 14:47 - Psychosis and Hallucination 15:19 - Management of Psychosis 15:41 - Acute Delirium vs Psychosis 16:03 - Caution: Memantine 16:14 - Seroquel (Quetiapine) 16:30 - Seroquel (Quetiapine) 16:46 - Clozaril (Clozapine): 17:21 - Clozaril (Clozapine): Side Effects: 17:40 - Clozapine: Drug Interactions 17:48 - Nuplazid (Pimavanserin) 18:27 - Nuplazid (Pimavanserin) 19:02 - Nuplazid (Pimavanserin) 19:16 - Melatonin 19:55 - Melatonin Pathway 20:07 - For More Information 20:16 - References 20:18 - References, Cont. 20:18 - References, Cont. 20:19 - References, Cont. 20:23 - References, Cont.
Views: 383 wcrdm8
Reducing antipsychotics in older adults with dementia
Use of antipsychotics for the symptoms of dementia in community-dwelling adults aged ≥65 is common despite modest benefits and serious risks.
anticholienrgic drugs associated with dementia
A commonly used over the counter drug causes dementia… next Anticholinergic Medications May Be Linked To Increased Dementia Risk Mandy Oaklander writing in Time reported researchers “analyzed already existing data from 451 people around ages 70-75 who had normal brains,” then “examined the results of memory tests, MRI brain scans and other neuroimaging data – all while paying particular attention to people who said they took anticholinergic” medications. Seniors “who regularly took at least one anticholinergic drug- sold over the counter and by prescription as sleep aids and for chronic diseases including hypertension, cardiovascular disease and chronic obstructive pulmonary disease according to Ben Tinker of CNN- showed poorer cognition, lower brain volumes and less glucose metabolism in the whole brain and the temporal lobe” than seniors who did not. The study was published online in JAMA Neurology. Comment: Wow. The list of what we can take that doesn’t cause bad side effects is shrinking fast.
Views: 193 Nathan Wei
Neuroleptic malignant syndrome
Neuroleptic malignant syndrome (NMS) is a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic drugs. NMS typically consists of muscle rigidity, fever, autonomic instability, and cognitive changes such as delirium, and is associated with elevated plasma creatine phosphokinase. The incidence of neuroleptic malignant syndrome has decreased since it was first described, due to changes in prescribing habits, but NMS is still a potential danger to patients being treated with antipsychotic medication. Because of the unpredictability of NMS, treatment may vary substantially but is generally based on supportive care and removal of the offending antipsychotic drug. This video is targeted to blind users. Attribution: Article text available under CC-BY-SA Creative Commons image source in video
Views: 8394 Audiopedia
How To Cure Alzheimer Disease & Dementia Treatment & How To Treat Mild Dementia
STOP DEMENTIA TODAY - http://www.TreatDementiaNaturally.com - If you seriously want to find out how to treat dementia properly and with real results, click on the link now! 0:01 - how to treat dementia ===================== "I was nervous that this program would be complicated and too difficult to even bother with. Boy, was I wrong. The information was simple and easy to learn. I just looked up what I needed, followed the plan and in a few days, I felt better than I had in my life! Mike Malkovic" "I'm a natural skeptic, but I decided to give it a try. I got to admit that these insights just blew me away from page one. I never knew it could be this easy to feel great. I'm 81 but I feel like I'm 42 Gabriel H." ===================== Search Terms: how to stop wandering in alzheimer's, how to prevent having alzheimer, how to stop getting alzheimer's, how to prevent alzheimer's from getting worse, how to prevent alzheimer early,
Views: 8 Frank Ortenzio
Fred - Parkinson's Disease, Dementia, Memory Loss
Date Recorded: 02/25/2014 Fred's wife, Isela, speaks on his behalf. Fred was diagnosed with Parkinson's Disease 13 years ago and suffered from severe symptoms of the disease including hand tremors, loss of balance, and sudden involuntary movements. Isela reports that Fred would involuntarily swing his arms and legs about at night while in bed. His poor coordination and imbalance also resulted in 4 hospital visits with fractured limbs. Fred was prescribed Seroquel and Namenda, which only lead him to experience side-effects such as memory loss, hallucination, confusion, and somnolence. After hearing about Dr. Tong through a friend, Fred came in for his first NBE treatment. Since the very first treatment, he stopped having involuntary spasms at night. Through the progress of treatments, Fred's hand tremors have significantly been reduced and he is able to retain information better than before. Listen to this incredible story that Fred and Isela share with us.
Views: 1408 Dr. Tong
When Anti-Psychotic Medications are Appropriate
2016-10-19 11.59 When anti-psychotic medications are appropriate
Views: 397 ORGovDHS
Living Well with Endocrine Effects of Atypical Antipsychotics 1
Giving info on how to cope with adverse effects of atypical antipsychotics to a patient.
Views: 399 tomfjohnson
Medications in dementia antipsychotics and antidepressants
I was honoured and thrilled to be at Prof Sube Banerjee's inaugural lecture at the Brighton and Sussex Medical School on 'Reasons to be cheerful'. The lecture was essentially a timely synopsis on 26 February 2014, signposting the critical importance that living well with dementia will take in English policy in the next five years. Video taken by Dr Shibley Rahman, a guest of the School for the lecture. [Details: http://www.bsms.ac.uk/about/event/inaugural-lecture-professor-sube-banerjee/]
Views: 255 Shibley Rahman
Risperdal Side Effect Attorney in Houston, TX - Richard Plezia
Also known as Risperidone, Risperdal is an antipsychotic prescription medication that is used to treat certain mood, mental health, and emotional disorders. These include but are not limited to bipolar disorder, schizophrenia, and even the irritability associated with an autistic disorder. The drug works to restore the balance of certain natural chemicals and substances in the brain. Unfortunately, Risperdal has been shown to have certain adverse effects, especially in seniors with dementia and teens. As with any over the counter or prescription medication, side effects can happen. However, Risperdal has been shown to cause several conditions that patients were not properly warned about. Risperdal and Gynecomastia: This condition is the development or an enlargement of breast tissue in males. Gynecomastia has been linked to the drug causing the body to produce a hormone common in women who are nursing or pregnant known as prolactin. The condition is regrettably more common in children and teens that take Risperdal. This breast tissue development is usually permanent and requires surgical removal by a plastic or reconstructive surgeon. The side effects were well known to the manufacturers of Risperdal. For more information about my firm, visit our educational website at http://www.rickplezia.com/defective-devices-and-drugs/risperdal/, where you can view more information about Risperdal side effects. If you have legal questions, I want you to call me at (713) 800-1151. I welcome your call. Richard J. Plezia & Associates 11200 Westheimer Road #620 Houston, TX 77042 (713) 800-1151 http://www.rickplezia.com
Views: 429 rplezia
Exclusive Investigation, Drugging Dementia
LBDU's Ask the Expert
LBDA is proud to present LBD University: Ask the Expert. This series of short videos and educational webinars provides the opportunities for both LBD families and healthcare professionals to ask leading experts questions. Topics to be featured in 2016 include clinical trials, LBD clinical care, and advances in LBD research. Interested in learning more about LBD clinical care? Join us later this year when our LBD University webinar, Ask the Expert will feature Dr. Bradley F. Boeve. Dr. Boeve, a member of LBDA’s Scientific Advisory Council, is the Chair of the Enterprise Subspecialty of Behavioral Neurology of Mayo Clinic, Chair of the Division of Behavioral Neurology at Mayo Clinic Rochester, and is Professor of Neurology in the Mayo Clinic College of Medicine. Watch for the registration announcement by subscribing to the Lewy Body Digest e-newsletter. Sign up today at https://www.lbda.org/ !
Views: 1140 LBDAtv
Parkinson's: The Latest Approaches
"Falls, hallucinations, depression, dementia... everyone knows about the Masked Face of Parkinson's but what about the rest!" Associate Professor Simon Lewis Parkinson's disease is a chronic life long condition. It is the most common neurodegenerative disorder in Australia after Alzheimer's disease, with gradual onset and slow progression. Symptoms include tremor, rigidity, slowness of movement and impaired balance. The presentation of symptoms varies greatly between individuals diagnosed and no two people will be affected in the same way. A primary health care practice of 1,700 patients would have, on average, 4 patients with Parkinson's disease. Rural living is a statistically significant risk factor. This debilitating condition presents many and varied challenges for both the person with Parkinson's and their carers. With no known cure, treatment aims to minimise the impact of the symptoms on the person's quality of life. The individual treatment regimen needs to be reviewed and, when necessary, modified as the disease progresses. As with any complex chronic medical condition, management of people with Parkinson's can be enhanced by the holistic and ongoing care of a multidisciplinary health care team. This program looks at the latest advances in diagnosis, treatment and ongoing management of symptoms. Different models of care are examined, and the evidence-based pharmacological and non-pharmacological treatments are discussed. Produced by the Rural Health Education Foundation http://www.rhef.com.au/
Views: 3830 Rural Health Channel
Moving Forward: Sleep Disturbances and Movement Disorders
UW Health movement disorders doctor Mihaela H. Bazalakova talks about the relationship between sleep and movement disorders like Parkinson's disease.
Views: 393 UW Health
Parkinson's Fundraiser
We are raising money to fund a microgrant for Dr. Dan Leventhal's research at the University of Michigan. Learn about what Parkinson's Disease is, and how it affects family members in this video. http://www.youcaring.com/dr-daniel-k-l-leventhal-s-research-team-369816 ----------------------------------------------------------- Royalty free music from incompetech.com Easy Lemon by Kevin MacLeod Sovereign Quarter by Kevin MacLeod
Views: 83 Natsume Ono
Q&A 16 - Questioning Antidepressant Efficacy, Anticholinergic Deliriants (& More)
In this video I discuss my thoughts on 4-FA's neurotoxicity, critiques of antidepressants, 5-MeO-DMT, and more. Timestamps 00:19 - "What are your thoughts on 4-FA being a strong neurotoxic compound due to its similarity with 4-CA?" 01:03 - "This model, that model, "might," "maybe," "could," -- they have no idea how any of these SSRI/SNRI drugs work or even if they work." 02:52 - "What causes the brain to be delusional? Is there a relationship between scopolamine and diphenhydramine?" 04:17 - "This is a propaganda video! This is a sacred medicine which requires respect and is not for everyone." (in regards to 5-MeO-DMT) 05:30 - "I suffer from really bad anxiety, what would you recommend?" Reddit discussion: https://www.reddit.com/r/TheDrugClassroom/comments/75but8/qa_16_questioning_antidepressant_efficacy/ ------------ Donate to The Drug Classroom: https://www.patreon.com/TheDrugClassroom https://www.paypal.me/TheDrugClassroom Bitcoin: 1HsjCYpBHKcVCaW4uKBraCGkc1LK8xoj1B ------------ Thank you to my Patreon supporters: RollSafe.org, Jonathon Dunn, Thomas Anaya, michael hoogwater, Beau Jaco, Alexander Pavlenko, Lars Nilsson, Billy, Abdulaziz Al-Kuwari, Sam A., Reece hosford, Felix Wisniewski, Jarrod o'connell, Daniel X Moore, Dahmon Bicheno, Christoffer Finstad, Zachary Thomas Binkley, Sami Parsegov, Dane Overman, Squadra Dumay, Dragonhax, Case van der Burg, John Riccardi, Matúš Zdút, Sebastian, Jacob Fournier-Paradis, and David Kernell. ------------ Facebook - http://facebook.com/thedrugclassroom Twitter - http://twitter.com/drugclassroom Email - seth@thedrugclassroom.com ------------ The Drug Classroom (TDC) is dedicated to providing the type of drug education everyone should have. Drugs are never going to leave our society and there has never been a society free from drugs. Therefore, it only makes sense to provide real education free from propaganda. TDC doesn't advocate drug use. Rather, we operate with the intention of reducing the harm some substances can bring. Feel free to ask questions!
Views: 5486 The Drug Classroom
Manejo de las alteraciones de conducta en la demencia
1. Introducción La prevalencia de la demencia se sitúa entre el 5 y el 10% de las personas de más de 65 años. El 90% de los casos sufrirá síntomas conductuales o psicológicos relacionados con la enfermedad. Los síntomas conductuales más frecuentes son: insomnio, agitación, agresividad física y verbal, deambulación errática, desinhibición sexual, hiperoralidad y acumulación. Los síntomas psicológicos son: cambios de personalidad, ansiedad, depresión, alucinaciones, ideación delirante y apatía. Ambos tipos de síntomas suelen tener interés a la hora de hacer un diagnóstico del tipo de demencia, pero en este caso los vamos a englobar a todos en un conjunto porque todos pueden presentarse en cualquier tipo de demencia. El doctor Alejandro García Caballero nos explicará, a continuación, cuál debe ser el abordaje de estas alteraciones y síntomas en las demencias. 2.Sobre el experto Alejandro García Caballero es Licenciado en Medicina por la Universidad de Santiago de Compostela y Especialista en Psiquiatría. Además, es Experto Universitario en Psiquiatría Forense (UNED). Fue Premio Extraordinario de doctorado de la Universidad de Santiago con una tesis sobre diagnóstico de demencia. Actualmente dirige la Unidad de Psicogeriatría del Complexo Hospitalario Universitario de Ourense. 3.Objetivos Caracterizar los diferentes tipos de alteraciones de conducta que se presentan en las demencias. Realizar un diagnóstico diferencial adecuado. Conocer los principios de las intervenciones no farmacológicas y proporcionar educación sanitaria a los cuidadores. Realizar un tratamiento farmacológico correcto.
Views: 12686 P2P Asistencial